-
-
-
-
-
-
-
ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
-
-
-
-
-
-
-
AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
-
-
-
-
-
-
-
Vifor Pharma and ChemoCentryx (CCXI) Expand Avacopan Agreement
-
-
-
-
-
-
-
Pre-Open Stock Movers 12/04: (OCLS) (PLUG) (OMED) Higher; (AMBI) (EXPR) (OVTI) Lower (more...)
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

